Viemed Healthcare (VMD) Gross Margin (2018 - 2026)
Viemed Healthcare (VMD) posted Gross Margin of 56.79% for Q1 2026, down 1.91% on a QoQ basis from 57.89% in Q4 2025, and up 51.0% year-over-year from 37.61% in Q1 2025.
Viemed Healthcare (VMD) Gross Margin (2018 - 2026) Analysis & Trends
Viemed Healthcare's Gross Margin history runs 9 years deep, the most recent figure standing at 56.79% for Q1 2026.
- Quarterly Gross Margin rose 51.0% year-over-year to 56.79% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 57.58% (down 113.0% YoY) and the FY2025 annual result came in at 57.52%, down 188.0% from the prior year.
- Gross Margin was 56.79% for Q1 2026 at Viemed Healthcare, down from 57.89% in the prior quarter.
- Across five years, Gross Margin topped out at 63.29% in Q4 2023 and bottomed at 56.28% in Q1 2025.
- A 5-year average of 59.67% and a median of 59.84% in 2024 frame the typical range for Gross Margin.
- Annual changes were most pronounced in 2023 — Gross Margin surged 224 bps — and 2024, when it slumped 375 bps.
- Viemed Healthcare's Gross Margin stood at 61.04% in 2022, then advanced by 4 bps to 63.29% in 2023, then retreated by 6 bps to 59.54% in 2024, then dropped by 3 bps to 57.89% in 2025, then retreated by 2 bps to 56.79% in 2026.
- Business Quant data shows VMD's Gross Margin at 56.79% in Q1 2026, 57.89% in Q4 2025, and 57.49% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 56.20% |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 63.29% |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 65.35% |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 69.46% |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 78.01% |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 62.95% |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 45.22% |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 38.53% |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Viemed Healthcare | 448.46 Mn | 440.63 Mn | 42.83 Mn | 56.79% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 56.79% |
| Dec 31, 2025 | 57.89% |
| Sep 30, 2025 | 57.49% |
| Jun 30, 2025 | 58.25% |
| Mar 31, 2025 | 56.28% |
| Dec 31, 2024 | 59.54% |
| Sep 30, 2024 | 59.26% |
| Jun 30, 2024 | 59.84% |
| Mar 31, 2024 | 58.91% |
| Dec 31, 2023 | 63.29% |
| Sep 30, 2023 | 61.86% |
| Jun 30, 2023 | 60.28% |
| Mar 31, 2023 | 60.68% |
| Dec 31, 2022 | 61.04% |
| Sep 30, 2022 | 60.55% |
| Jun 30, 2022 | 61.21% |
| Mar 31, 2022 | 61.21% |
| Dec 31, 2021 | 61.52% |
| Sep 30, 2021 | 62.77% |
| Jun 30, 2021 | 64.33% |